跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Glyzeric - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Glyzeric
Approved
STANDARD
Glyzeric
Ajanta Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
be99d541d6a0caed
Company
Ajanta Pharma Limited
Type
Standard
Approval Details
Approval Id
be99d541d6a0caed
Drug Approval Philippines Name
Glyzeric
Product Name
Glyzeric
Registration Number
DR-XY43024
Brand Name
Glyzeric
Generic Name
Metformin hydrochloride + Gliclazide
Dosage Form
Film-Coated Tablet
Dosage Strength
850mg/80mg
Manufacturer
Ajanta Pharma Limited
Importer
Ajanta Pharma Philippines, Inc.
Distributor
Ajanta Pharma Philippines, Inc.
Company Detail Path
/organization/ajanta-pharma-limited
Issuance Date
24 January 2024
Expiry Date
27 November 2028
Pharmacologic Category
Oral Hypoglycemic (Biguanide-Sulfonylurea Combination)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
be99d541d6a0caed
Type
Standard
Back to Philippines FDA Approvals